Effect of revision of Japanese diagnostic criterion for fever in Kawasaki disease on treatment and cardiovascular outcome

Circulation Journal

Volumn 71, Issue 11, 2007, Pages 1791-1793

  Muta, Hiromi ^a   Ishii, Masahiro ^b   Iemura, Motofumi ^a   Suda, Kenji ^a   Nakamura, Yosikazu ^c   Matsuishi, Toyojiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiovascular diseases; Diagnosis; Kawasaki disease

Indexed keywords

IMMUNOGLOBULIN;

ADOLESCENT; ADULT; ANEURYSM; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHILD; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEALTH SURVEY; HEART INFARCTION; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECURRENT DISEASE; STENOSIS;

ADOLESCENT; ADULT; CARDIOVASCULAR DISEASES; CHILD; DATABASES AS TOPIC; FEMALE; FEVER; GUIDELINES AS TOPIC; HEALTH SURVEYS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MUCOCUTANEOUS LYMPH NODE SYNDROME; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME;

EID: 36948999016     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1791     Document Type: Article

References (13)

1. Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 1967; 16: 178-222 (in Japanese).
2. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation 2004; 110: 2747-2771.
3. Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: Comparison of therapeutic regimens. Circ J 2005; 69: 265-272.
4. Baba R, Shibata A, Tsurusawa M. Single high-dose intravenous immunoglobulin therapy for Kawasaki disease increases plasma viscosity. Circ J 2005; 69: 962-964.
5. Yanagawa H, Nakamura Y, Yashiro M. Results of the 16th nationwide survey of Kawasaki disease in Japan. Jpn J Pediatr Pract 2002; 65: 332-342 (in Japanese).
6. Nakamura Y, Yashiro M, Uehara R, Oki I, Kayaba K, Yanagawa H. Results of the 18th nationwide survey of Kawasaki disease in Japan. Jpn J Pediatr Pract 2006; 69: 281-292 (in Japanese).
7. Ayusawa M, Sonobe T, Uemura S, Ogawa S, Nakamura Y, Kiyosawa N, et al. Revisions of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr Int 2005; 47: 232-234.
8. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364: 533-544.
9. Tse SML, Silverman LD, McCrindle BW, Yeung RSM. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease. J Pediatr 2002; 140: 450-455.
10. Muta H, Ishii M, Egami K, Furui J, Sugahara Y, Akagi T, et al. Early intravenous gamma-globulin treatment for Kawasaki disease: The nationwide surveys in Japan. J Pediatr 2004; 144: 496-499.
11. Yanagawa H, Nakamura Y, Yashiro M, Oki I, Hirata S, Zhang T, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001; 107: Available at http://www.pediatrics.org/cgi/ content/full/107/3/e33
12. Research Committee on Kawasaki Disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Tokyo, Japan: Ministry of Health and Welfare.
13. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133: 254-258.